相关实验视频

Updated: Jun 10, 2026

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.1K

精确治疗人类表皮生长因子受体2-增强型晚期直肠癌:一个病例报告

Xia Xiao1, Qing-Wen Wang2, Zheng-Yang Zhou2

  • 1Department of Oncology, Wuxi No. 2 People's Hospital, Jiangnan University Medical Center, Wuxi 214002, Jiangsu Province, China.

World journal of gastrointestinal oncology
|April 16, 2025
PubMed
概括

免疫检查点抑制剂 (ICI) 与pyrotinib结合,在患有对标准治疗有抗性的HER2增强型晚期直肠癌的患者中显示出显著的疗效. 这种组合治疗,包括化疗,为耐火病例提供了一个有希望的方法.

关键词:
案例报告案例报告化疗 化疗是一种化学疗法.人类表皮生长因子受体2 人类表皮生长因子受体2编程死亡 1 编程死亡 1皮罗丁尼布 (Pyrotinib) 是一种酸盐.这是直肠癌.

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

5.4K

相关概念视频

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...